Advertisement

Macrolides and upper airway/sinus disease

  • Kazuhiko Takeuchi
  • Yuichi Majima
  • Qutayba Hamid
Chapter
Part of the Progress in Inflammation Research book series (PIR)

Keywords

Otitis Medium Nasal Polyp Chronic Rhinosinusitis Macrolide Antibiotic Chronic Sinusitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kudoh S, Uetake T, Hagiwara K, Hirayama M, Hus LH, Kimura H, Sugiyama Y (1987) Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Jpn J Thorac Dis 25: 632–42Google Scholar
  2. 2.
    Kikuchi S, Suzaki H, Aoki A, Ito O, Nomura Y (1991) Clinical effect of long-term low dose erythromycin therapy for chronic sinusitis. Pract Otol (Kyoto) 84: 41–7Google Scholar
  3. 3.
    Hashiba M, Baba S (1996) Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol (Suppl) 525: 73–8Google Scholar
  4. 4.
    Kimura N, Nishioka K, Nishizaki K, Ogawa T, Naitou Y, Masuda Y (1997) Clinical effect of low-dose, long-term roxithromycin chemotherapy in patients with chronic sinusitis. Acta Med Okayama 51: 33–7PubMedGoogle Scholar
  5. 5.
    Kita H, Takezawa H, Isobe M, Kataura A (1995) Long-term low dose erythromycin (EM) and roxithromycin (RXM) therapy for chronic sinusitis. Pract Otol (Kyoto) (Suppl) 84: 62–9Google Scholar
  6. 6.
    Hashiba M, Baba S, Tohnai A, Okajima H, Matsuda T, Hondo J, Ohya H, Yokota A, Koto A, Ito M et al (1997) Clinical efficacy of long-term macrolides therapy for chronic sinusitis-comparison between erythromycin and clarithromycin. Pract Otol (Kyoto) 90: 717–27Google Scholar
  7. 7.
    Felstead SJ, Daniel R (1991) Short-course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group. J Int Med Res 19: 363–72PubMedGoogle Scholar
  8. 8.
    Hashiba M, Suzaki H, Furuta S, Yanagi K, Ohyama M, Baba S (1998) Guideline for macrolide treatment of chronic paranasal sinusitis (draft). Jpn J Antibiot 51(Suppl A): 86–9PubMedGoogle Scholar
  9. 9.
    Nagai H, Shishido H, Yoneda R, Yamaguchi E, Tamura A, Kurashima A (1991) Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 58: 145–9PubMedGoogle Scholar
  10. 10.
    Shinkawa A, Sakai M (1996) Study on the duration of long-term administration of roxithromycin (RXM) in patients with chronic sinusitis. ORL Tokyo 39(Suppl 1): 108–11Google Scholar
  11. 11.
    MacLeod CM, Hamid QA, Cameron L, Tremblay C, Brisco W (2001) Anti-inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa. Adv Ther 18: 75–82PubMedGoogle Scholar
  12. 12.
    Suzuki H, Ikeda K, Honma R, Gotoh S, Oshima T, Furukawa M, Takasaka T (2000) Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. ORL J Otorhinolaryngol Relat Spec 62: 121–7PubMedGoogle Scholar
  13. 13.
    Hirano K, Ikeda K, Shimomura A, Ohshima T, Kondo Y, Takasaka T (1995) Clinical investigation of effectiveness and ineffectiveness in patients with chronic sinusitis in the treatment of newly developed macrolides. ORL Tokyo 38(Suppl 3): 251–7Google Scholar
  14. 14.
    Steinke JW, Borish L (2003) Clarification of terminology in patients with eosionopilic and noneosinophilic hyperplastic rhinosinusitis. Author reply. J Allergy Clin Immunol 112: 222–3Google Scholar
  15. 15.
    Moriyama H, Yanagi K, Ohtori N, Fukami M (1995) Evaluation of endoscopic sinus surgery for chronic sinusitis: post-operative erythromycin therapy. Rhinology 33:166–70PubMedGoogle Scholar
  16. 16.
    Cervin A, Kalm O, Sandkull P, Lindberg S (2002) One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg 126:481–9CrossRefPubMedGoogle Scholar
  17. 17.
    Suzuki H, Shimomura A, Ikeda K, Oshima T, Takasaka T (1997) Effects of long-term low-dose macrolide administration on neutrophil recruitment and IL-8 in the nasal discharge of chronic sinusitis patients. Tohoku J Exp Med 182: 115–24PubMedGoogle Scholar
  18. 18.
    Fujita K, Shimizu T, Majima Y, Sakakura Y (2000) Effects of macrolides on interleukin-8 secretion from human nasal epithelial cells. Eur Arch Otorhinolaryngol 257: 199–204CrossRefPubMedGoogle Scholar
  19. 19.
    Shimizu T, Shimizu S, Hattori R, Gabazza EC, Majima Y (2003) In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells. Am J Respir Crit Care Med 168: 581–7CrossRefPubMedGoogle Scholar
  20. 20.
    Kim DY, Takeuchi K, Ishinaga H, Kishioka C, Suzuki S, Basbaum C, Majima Y (2004) Roxithromycin suppresses mucin gene expression in epithelial cells. Pharmacology 72:6–11CrossRefPubMedGoogle Scholar
  21. 21.
    Rhee CS, Majima Y, Arima S, Jung HW, Jinn TH, Min YG, Sakakura Y (2000) Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis. Ann Otol Rhinol Laryngol 109: 484–7PubMedGoogle Scholar
  22. 22.
    Kondoh K, Hashiba M, Baba S (1996) Inhibitory activity of clarithromycin on biofilm synthesis with Pseudomonas aeruginosa. Acta Otolaryngol (Suppl) 525: 56–60Google Scholar
  23. 23.
    Ozeki M, Miyamoto N, Hashiba M, Baba S (1996) Inhibitory effect of roxithromycin on biofilm formation of Pseudomonas aeruginosa. Acta Otolaryngol (Suppl) 525: 61–3Google Scholar
  24. 24.
    Ichimura K, Shimazaki Y, Ishibashi T, Higo R (1996) Effect of new macrolide roxithromyci upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx 23: 48–56PubMedGoogle Scholar
  25. 25.
    Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H (2000) Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 14: 143–8PubMedGoogle Scholar
  26. 26.
    Nonaka M, Pawankar R, Tomiyama S, Yagi T (1999) A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts. Am J Rhinol 13(4): 267–72PubMedGoogle Scholar
  27. 27.
    Iino Y, Sugita K, Toriyama M, Kudo K (1993) Erythromycin therapy for otitis media with effusion in sinobronchial syndrome. Arch Otolaryngol Head Neck Surg 119: 648–51PubMedGoogle Scholar
  28. 28.
    Iino Y, Sugita K, Ishitoya J, Nakai A, Ambe K, Masuda T, Shimizu H, Toriyama M (1992) Erythromycin treatment for otitis media with effusion in children. Pract Otol (Kyoto) 85: 713–20Google Scholar
  29. 29.
    Iino Y (2001) Efficacy of macrolide therapy for children with serous otitis media. Jpn J Antibiot 54(Suppl) C:23–5Google Scholar
  30. 30.
    Enomoto F, Ichikawa G, Nagaoka I, Yamashita T (1998) Effect of erythromycin on otitis media with effusion in experimental rat model. Acta Otolaryngol (Suppl)539: 57–60CrossRefGoogle Scholar

Copyright information

© Hirkhäuser Verlag Basel/Switzerland 2005

Authors and Affiliations

  • Kazuhiko Takeuchi
    • 1
  • Yuichi Majima
    • 1
  • Qutayba Hamid
    • 2
  1. 1.Department of OtorhinolaryngologyMie University School of MedicineJapan
  2. 2.McGill UniversityCanada

Personalised recommendations